British Study Finds That 60 Percent of Individuals Aged 60 Above Exposed to SARS-CoV-2 Will Develop Dementia!

Medical-News: Understanding the Connection Between COVID 19 and Dementia
COVID-19, caused by the SARS-CoV-2 virus, has disrupted lives worldwide, leaving a trail of medical and societal challenges. Beyond its acute effects, growing evidence highlights its potential long-term neurological impacts, especially in older adults. A recently published study examines the association between COVID-19 infections and the development of new-onset dementia (NOD) in individuals aged 60 years and above.


Individuals Aged 60 Above Exposed to SARS-CoV-2 Will Have A 60 Percent Higher Likelihood of Developing Dementia

Researchers from Lancaster University’s Centre for Ageing Research, the University of Oxford’s Department of Psychiatry, and the Department of Psychology at Lancaster University collaborated on this investigation. This Medical News report delves into the findings and implications of their comprehensive systematic review and meta-analysis.
 
The Growing Concern Over Post COVID Cognitive Impairment
COVID-19 has been linked to several post-acute sequelae, with neurological disorders like “brain fog”, memory impairments, and even dementia among the most concerning. This study reviewed data from January 2020 to December 2023, analyzing results from 11 studies that collectively involved nearly 940,000 COVID-19 survivors and over 6.7 million controls. The researchers sought to understand whether older adults recovering from COVID-19 faced a higher risk of developing dementia compared to those who did not contract the virus.
 
The research brings to light alarming findings. The overall incidence of NOD among COVID-19 survivors was approximately 1.82%, compared to just 0.35% in the non-COVID control group. This indicates that older adults recovering from COVID-19 have a significantly higher risk of developing dementia within 12 months of infection. The pooled analysis reported a risk ratio (RR) of 1.58, reflecting a nearly 60% higher likelihood of dementia in the COVID-19 group.
 
How the Study Was Conducted
The researchers employed rigorous methods to ensure the reliability of their findings. They analyzed data from major databases, including MEDLINE/PubMed, PsycINFO, and Scopus. The selected studies included both retrospective and prospective cohorts, focusing specifically on individuals aged 60 and above.

Subgroup analyses were conducted to explore differences in dementia risk based on factors such as sex, type of respiratory infection, and the severity of COVID-19 symptoms. Five studies utilized Propensity Score Matching (PSM) to control for confounding variables, ensuring a more accurate comparison between COVID-19 and non-COVID cohorts.
 
Key Findings from the Study
-Increased Risk Over Time: The risk of developing dementia was most pronounced at the 12-month follow-up. At this point, COVID-19 survivors exhibited a significantly elevated risk (RR = 1.56) compared to non-COVID controls.
 
-Comparison Wi th Other Respiratory Infections: The researchers found that the risk of dementia in COVID-19 survivors was comparable to those who had experienced other severe respiratory infections, such as influenza. However, COVID-19’s unique mechanisms, such as systemic inflammation and potential central nervous system involvement, may exacerbate this risk.
 
-Severity of COVID-19 Symptoms: The analysis revealed a stark contrast between mild and severe cases. Older adults hospitalized with severe COVID-19 were up to three times more likely to develop dementia than those who managed their infection at home.
 
-Demographic and Health Factors: Women were slightly more likely than men to develop NOD following COVID-19, although this trend also mirrored general patterns in dementia prevalence. Pre-existing cardiovascular conditions further amplified the risk.
 
Mechanisms Linking COVID 19 to Dementia
The study proposes several biological mechanisms to explain the observed increase in dementia risk:
 
-Inflammation and Neurodegeneration: COVID-19 is associated with heightened inflammation, which can accelerate neurodegenerative processes.
 
-Vascular Damage: The virus’s ability to induce blood clots and disrupt oxygen supply to the brain aligns with mechanisms underlying vascular dementia.
 
-Direct Viral Impact: Emerging evidence suggests that SARS-CoV-2 may invade the central nervous system, leading to long-term damage.
 
The Implications of These Findings
The association between COVID-19 and dementia highlights the need for targeted post-recovery care in older adults. Early detection and intervention could mitigate the cognitive decline observed in survivors. Strategies such as routine cognitive screenings, mental health support, and rehabilitation programs tailored to COVID-19 survivors could prove invaluable.
 
Limitations and Future Directions
While the study provides robust evidence, several limitations must be acknowledged:
 
-Heterogeneity Among Studies: Variations in study design, follow-up periods, and diagnostic criteria may introduce inconsistencies.
 
-Limited Long-Term Data: Most studies focused on a 12-month follow-up. Longer observation periods are needed to understand the full trajectory of COVID-19’s neurological impacts.
 
-Unaddressed Confounders: Factors like vaccination status and the effects of repeated infections remain underexplored.
 
Future research should aim to address these gaps. Understanding the impact of preventive measures, such as vaccination, on dementia risk could offer valuable insights.
 
Conclusions
The findings of this study underscore the serious long-term neurological risks associated with COVID-19 in older adults. The evidence suggests that recovering from COVID-19 significantly increases the risk of developing new-onset dementia, with the highest risk observed at 12 months post-infection. This elevated risk is likely due to a combination of systemic inflammation, direct viral effects on the brain, and exacerbation of pre-existing vulnerabilities.
 
It is crucial to prioritize the neurological health of COVID-19 survivors, particularly older adults. Governments, healthcare providers, and researchers must collaborate to develop strategies that address the long-term consequences of the pandemic. Proactive measures, including enhanced cognitive screenings, rehabilitation, and public awareness campaigns, can help mitigate the burden of dementia in this vulnerable population.
 
The study findings were published in the peer-reviewed journal: BMC Geriatrics.
https://link.springer.com/article/10.1186/s12877-024-05538-5
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/breaking-coronavirus-news-cleveland-clinic-study-shows-that-covid-19-infections-can-lead-to-alzheimer-s-disease-like-dementia
 
https://www.thailandmedical.news/news/neuro-covid-university-of-michigan-academic-warns-of-potential-memory-loss-and-dementia-in-covid-19-patients
 
https://www.thailandmedical.news/news/strategies-to-combat-covid-19-linked-brain-amyloids-and-dementia-alzheimer
https://www.thailandmedical.news/articles/coronavirus